| Literature DB >> 32656121 |
Ahmed Reda Aldahshory1, Hazem Mashaly2, Shafik Tahseen El Molla2, Ibrahim Abdelmohsen Ismaiel2, Khaled Saoud2.
Abstract
BACKGROUND: The classic laminectomy for spinal decompression was the treatment of choice of the degenerative lumbar canal stenosis (LCS). Many surgeons prefer to add instrumented lumbar fusion to avoid future instability after the removal of posterior elements. Adding fusion is associated with more bleeding and longer periods of hospitalization. Minimally invasive lumbar decompression (MILD) has been advocated for successful decompression with less bleeding loss and shorter hospitalization. AIM OF THE WORK: To evaluate and compare the clinical outcomes of two different treatment modalities for degenerative LCS: the classic laminectomy with posterolateral transpedicular screw fixation and the MILD. PATIENTS AND METHODS: Fifty patients with degenerative LCS were randomized from two institutions: Ain Shams University Hospital and Arab Contractors Medical Center, who underwent surgeries for degenerative LCS between 2016 and 2018 with 1-year follow-up. The study compared two cohorts: Group A - 25 patients underwent classic lumbar laminectomy with posterolateral transpedicular fixation, and Group B - 25 patients underwent MILD.Entities:
Keywords: Canal stenosis; classic laminectomy; degenerative lumbar; minimally invasive lumbar decompression; posterolateral transpedicular fixation
Year: 2020 PMID: 32656121 PMCID: PMC7335112 DOI: 10.4103/ajns.AJNS_132_20
Source DB: PubMed Journal: Asian J Neurosurg
Patient satisfaction index used in this study[11]
| Score | Patient responses |
|---|---|
| 1 | Surgery met my expectations |
| 2 | I did not improve as much as I had hoped, but I would undergo the same operation for the same results |
| 3 | Surgery helped, but I would not undergo the same operation for the same outcome |
| 4 | I am the same or worse as compared to before surgery |
Demographic data of both groups
| Fusion group ( | Mild group ( | Test value | Significance | ||
|---|---|---|---|---|---|
| Age | |||||
| Mean±SD | 54.36±8.00 | 54.28±8.06 | 0.035** | 0.972 | NS |
| Range | 40-81 | 39-68 | |||
| Sex, | |||||
| Female | 0 (0.0) | 3 (12.0) | 3.191* | 0.074 | NS |
| Male | 25 (100.0) | 22 (88.0) |
*Chi-square test; **Independent t-test. P>0.05 – NS; P<0.05 – S; P<0.01 – HS. NS – Nonsignificant; SD – Standard deviation; HS – Highly significant; S – Significant
Preoperative clinical presentation of both groups
| Fusion group ( | MILD group ( | Test value** | Significance | ||
|---|---|---|---|---|---|
| VAS leg | |||||
| Mean±SD | 7.20±1.00 | 7.40±1.12 | −0.667 | 0.508 | NS |
| Range | 6-8 | 6-9 | |||
| VAS back | |||||
| Mean±SD | 4.56±1.36 | 4.60±1.66 | −0.093 | 0.926 | NS |
| Range | 2-6 | 2-7 | |||
| ODI | |||||
| Mean±SD | 46.76±9.90 | 50.88±10.14 | −1.453 | 0.153 | NS |
| Range | 32-68 | 26-62 |
*Chi-square test; **Independent t-test. P>0.05 - NS; P<0.05 - Significant; P<0.01 - Highly significant. VAS – Visual analog score; ODI – Oswestry disability index; SD – Standard deviation; NS – Nonsignificant; HS – Highly significant; S – Significant
Number of levels and their distribution
| Fusion group (%) | Mild group (%) | Test value** | Significance | ||
|---|---|---|---|---|---|
| Number of levels | |||||
| 1 | 7 (28.0) | 10 (40.0) | 3.029* | 0.387 | NS |
| 2 | 15 (60.0) | 9 (36.0) | |||
| 3 | 2 (8.0) | 4 (16.0) | |||
| 4 | 1 (4.0) | 2 (8.0) | |||
| Which level | |||||
| L1.2.3.4.5 | 0 (0.0) | 2 (8.0) | 8.446* | 0.295 | NS |
| L2.3.4.5 | 1 (4.0) | 2 (8.0) | |||
| L2.3.4.5.S1 | 1 (4.0) | 0 (0.0) | |||
| L3.4.5 | 13 (52.0) | 6 (24.0) | |||
| L3.4.5.S1 | 1 (4.0) | 2 (8.0) | |||
| L4.5 | 6 (24.0) | 10 (40.0) | |||
| L4.5.S1 | 2 (8.0) | 3 (12.0) | |||
| L5.S1 | 1 (4.0) | 0 (0.0) |
*Chi-square test; **Independent t-test. P>0.05 - NS; P<0.05 - Significant; P<0.01 - Highly significant. NS – Nonsignificant; HS – Highly significant; S – Significant
Difference between pre- and post-operative scores in the fusion group
| Fusion group ( | Test value** | Significance | |||||
|---|---|---|---|---|---|---|---|
| Pre | Immediate | 6 months | 1 year | ||||
| VAS leg | |||||||
| Mean±SD | 7.20±1.00 | 2.44±0.87 | 2.60±0.91 | 21.294 | 0.000 | HS | |
| Range | 6-8 | 1-4 | 2-4 | ||||
| VAS back | |||||||
| Mean±SD | 4.56±1.36 | 4.30±1.27 | 3.08±1.58 | 25.427 | 0.000 | HS | |
| Range | 2-6 | 3-6 | 1-6 | ||||
| ODI | |||||||
| Mean±SD | 46.76±9.90 | 29.16±9.33 | 19.52±7.97 | 11.210 | 0.000 | HS | |
| Range | 32-68 | 15-45 | 10-40 | ||||
**Paired t-test; ≠ - Wilcoxon test. P>0.05 - NS; P<0.05 - S; P<0.01 - HS. NS – Nonsignificant; HS – Highly significant; S – Significant; VAS – Visual analog score; SD – Standard deviation
Difference between pre-and post-operative scores in the mild group
| Mild group ( | Test value** | Significance | |||||
|---|---|---|---|---|---|---|---|
| Pre | Immediate | 6 months | 1 year | ||||
| VAS leg | |||||||
| Mean±SD | 7.40±1.12 | 2.60±0.91 | 2.44±0.87 | 16.695 | 0.000 | HS | |
| Range | 6-9 | 2-4 | 1-4 | ||||
| VAS back | |||||||
| Mean±SD | 4.60±1.66 | 3.59±1.10 | 3.56±1.56 | 5.024 | 0.031 | S | |
| Range | 2-7 | 3-5 | 2-6 | ||||
| ODI | |||||||
| Mean±SD | 50.88±10.14 | 25.08±8.42 | 25.12±9.23 | 13.814** | 0.000 | HS | |
| Range | 26-62 | 13-45 | 11-42 | ||||
**Paired t-test. P>0.05 - NS; P<0.05 - S; P<0.01 - HS. VAS – Visual analog score; ODI – Oswestry disability index; SD – Standard deviation; NS – Nonsignificant; HS – Highly significant; S – Significant
Comparison between visual analogue score values of back pain and leg pain between both groups immediate postoperative and after 1 year
| Fusion group ( | Mild group ( | Test value** | Significance | ||
|---|---|---|---|---|---|
| Immediate | |||||
| VAS leg | |||||
| Mean±SD | 2.44±0.87 | 2.60±0.91 | 0.634 | 0.529 | NS |
| Range | 1-4 | 2-4 | |||
| VAS back | |||||
| Mean±SD | 4.30±1.27 | 3.59±1.10 | 2.127 | 0.039 | S |
| Range | 3-6 | 3-5 | |||
| 1 year postoperative | |||||
| VAS leg | |||||
| Mean±SD | 2.60±0.91 | 2.44±0.87 | 0.634 | 0.529 | NS |
| Range | 2-4 | 1-4 | |||
| VAS back | |||||
| Mean±SD | 3.08±1.58 | 3.56±1.56 | −1.082 | 0.284 | NS |
| Range | 1-6 | 2-6 |
**Independent t-test. P>0.05 - NS; P<0.05 - S; P<0.01 - HS. NS – Nonsignificant; HS – Highly significant; S – Significant; VAS – Visual analogue score; SD – Standard deviation
Comparison between both groups in the mean Oswestry disability index values after 6 months and after 1 year postoperatively
| Difference | Fusion group ( | Mild group ( | Test value** | Significance | |
|---|---|---|---|---|---|
| ODI after 6 months | |||||
| Mean±SD | 29.16±9.33 | 25.08±8.42 | 1.623 | 0.111 | NS |
| Range | 15-45 | 13-45 | |||
| ODI after 1 year | |||||
| Mean±SD | 19.52±7.97 | 25.12±9.23 | −2.296 | 0.026 | S |
| Range | 10-40 | 11-42 |
**Independent t-test. P>0.05 - NS; P<0.05: S; P<0.01 - HS. NS – Nonsignificant; HS – Highly significant; S – Significant; ODI – Oswestry disability index; SD – Standard deviation
Mean Oswestry disability index change between preoperative and 6 months and 1 year, respectively
| Fusion group ( | Mild group ( | Test value** | Significance | ||
|---|---|---|---|---|---|
| Mean ODI change preoperatively and 6 months postoperativley | |||||
| Mean±SD | −17.60±14.91 | −25.80±14.08 | 1.999 | 0.051 | NS |
| Range | −45-3 | −47-14 | |||
| Mean ODI change preoperatively and 1 year postoperative | |||||
| Mean±SD | −27.24±12.1 | −25.76±9.32 | 0.980 | 0.332 | NS |
| Range | −46-7 | −42-8 |
**Independent t-test. P>0.05 - NS; P<0.05 - S; P<0.01 - HS. NS – Nonsignificant; HS – Highly significant; S – Significant; ODI – Oswestry disability index; SD – Standard deviation
Patient satisfaction index in both groups
| PSI | Fusion group, | Mild group | Test value** | Significance | |
|---|---|---|---|---|---|
| Grade I-II | 21 (84) | 22 (88) | 0.166 | 0.683 | NS |
| Grade III-IV | 4 (16) | 3 (12) |
**Independent t-test. P>0.05 - NS; P<0.05 - S; P<0.01 - HS. PSI – Patient satisfaction index; NS – Nonsignificant; HS – Highly significant; S – Significant
Blood loss and hospital stay are higher in the fusion group
| Fusion group ( | Mild group ( | Test value** | Significance | ||
|---|---|---|---|---|---|
| Operative time (h) | |||||
| Mean±SD | 3.24±1.16 | 3.33±1.30 | −0.263** | 0.794 | NS |
| Range | 2-6 | 2-6 | |||
| Blood loss (mL) | |||||
| Mean±SD | 422.00±185.45 | 298.00±116.76 | 2.829** | 0.007 | HS |
| Range | 150-1000 | 180-600 | |||
| Complications, | |||||
| No | 23 (92.0) | 21 (84.0) | 0.758* | 0.384 | NS |
| Yes | 2 (8.0) | 4 (16.0) | |||
| Hospital stay | |||||
| Mean±SD | 5.56±2.42 | 3.00±1.19 | 4.752** | 0.000 | HS |
| Range | 3-16 | 2-7 |
Blood loss and hospital stay are higher in the fusion group. They are equal in mean operative time and complications. *Chi-square test; **Independent t-test. P>0.05 - NS; P<0.05 - S; P<0.01 - HS. NS – Nonsignificant; HS – Highly significant; S – Significant; SD – Standard deviation
Cost per Egyptian pound of both treatment modalities
| Cost × 1000 Egyptian pound | Fusion group ( | Mild group ( | Test value** | Significance | |
|---|---|---|---|---|---|
| Mean±SD | 47.3±5.0 | 27.5±2.5 | 17.710 | <0.001 | HS |
| Range | 40-60 | 25-30 |
**Independent t-test. P>0.05 - NS; P<0.05 - S; P<0.01 - HS. NS – Nonsignificant; HS – Highly significant; S – Significant; SD – Standard deviation